Viewing nowCombinationBarodown Tablet 10/40 mg
Ezetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Samik Pharmaceutical Co., Ltd.

MFDS item code 202101501 · Approved 2021.02.18 · Insurance code 644004550
This product's status changed to Expired on 2026.02.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypercholesterolemia (including familial forms) and mixed dyslipidemia
This medication is used as an adjunct to dietary therapy in patients with primary hypercholesterolemia or mixed dyslipidemia to reduce total cholesterol, LDL-C, apo B, triglycerides, and non-HDL cholesterol levels, and to increase HDL-C levels. It also helps lower cholesterol levels in patients with homozygous familial hypercholesterolemia when administered alone or in conjunction with other therapies. This medication should be used along with dietary therapy during the treatment of dyslipidemia, and it is crucial to manage the patient's various risk factors appropriately. If there are other secondary causes, they should be treated first before this medication is administered. The treatment progress should be monitored by checking the lipid profile, including total cholesterol, LDL-C, HDL-C, and triglycerides. Therefore, this medication is used effectively to improve the blood lipid levels of patients with dyslipidemia and hypercholesterolemia.
Take this medicine once daily, with or without food. Patients must continue a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range is 10/10mg∼10/80mg once daily. The recommended starting dose is 10/10mg or 10/20mg once daily. For patients requiring a greater reduction in LDL cholesterol (55% or more), the recommended starting dose is 10/40mg once daily. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful.
This medication has been reported to cause a rare side effect called rhabdomyolysis, which can lead to severe muscle damage. If severe muscle pain or muscle weakness symptoms arise, consult a doctor immediately. Particularly, in cases with risk factors such as severe infection, hypotension, post-major surgery, trauma, metabolic disorders, endocrine issues, electrolyte imbalance, or uncontrolled seizures, the use of this medication should be temporarily suspended or discontinued. Patients with allergies to the active ingredients or components of this medication, active liver disease, unexplained elevation of liver enzymes, those with muscle diseases, pregnant or breastfeeding women, and patients taking certain antiviral drugs should not take this medication. Alcoholics, patients with moderate to severe liver dysfunction, renal impairment, hypothyroidism, a history of genetic muscle disease, elderly individuals, and those at high risk for myopathy should use this medication with caution. This medication contains Tartrazine (Yellow No. 4), so those allergic to this ingredient should take caution. During treatment, symptoms such as muscle pain, fatigue, and muscle pain with fever may occur, and if these symptoms arise, inform healthcare professionals immediately. Liver function abnormalities may occur, so liver function tests should be performed regularly before and during administration, and if symptoms such as nausea, vomiting, fatigue, or jaundice appear, administration should be discontinued. This medication may interact with many drugs, so if taking other medications, it is essential to inform the healthcare provider, especially with caution when combined with CYP3A4 inhibitors, cyclosporine, fibrate-class drugs, certain antibiotics, and antiviral agents. Pregnant women or women who may become pregnant should not take this medication, and women of childbearing age should use appropriate contraceptive methods while taking this medication. Breastfeeding women should also avoid taking this medication for safety. Safety and effectiveness have not been established for children, and it is not recommended. Elderly individuals are at high risk of myopathy, so caution is necessary when taking this medication, but dose adjustment is generally not required. Patients with severe renal or liver dysfunction should use this medication cautiously and may require dosage adjustment. There are no specific antidotes for overdose, so treatment should be symptomatic along with monitoring liver function and muscle enzyme levels. This medication should be stored out of the reach of children and should not be transferred to another container. Dizziness may occur during treatment, so caution should be exercised when driving or operating machinery.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering and is best kept at room temperature between 1 and 30 degrees Celsius.
White, oval film-coated tablet
30 tablets/box [10 tablets/Alu-Alu x 3], 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Samik Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.